Feb 24, 2026 09:00AM

Jan 29, 2026 06:21AM

Jan 20, 2026 09:15AM

Jan 20, 2026 09:15AM

Jan 16, 2026 07:11AM

Dec 22, 2025 07:06AM

Dec 21, 2025 04:00AM Biotechnology: Here are Piper Sandler's Top Picks and Focus Names for 2026

Dec 17, 2025 06:59AM

Dec 16, 2025 04:05PM

Dec 16, 2025 04:05PM

Dec 10, 2025 07:42AM

Dec 8, 2025 07:09AM

Dec 3, 2025 02:59PM

Dec 3, 2025 07:20AM Capricor reports positive phase 3 trial results for Duchenne therapy

Dec 3, 2025 07:20AM

Dec 3, 2025 07:20AM

Nov 10, 2025 04:01PM

Nov 3, 2025 09:15AM

Nov 3, 2025 09:15AM

Sep 25, 2025 07:15AM

Sep 25, 2025 07:15AM Capricor Therapeutics Provides Regulatory Update on Deramiocel Program for Duchenne Muscular Dystrophy Following Type A Meeting

Sep 18, 2025 05:08AM

Sep 12, 2025 06:46AM

Sep 9, 2025 09:23AM

Sep 9, 2025 09:20AM

Aug 19, 2025 06:40AM

Aug 18, 2025 09:00AM

Aug 18, 2025 09:00AM Capricor Therapeutics Announces First Subjects Dosed in Phase 1 Clinical Trial of Novel Exosome-Based Vaccine

Aug 11, 2025 04:05PM

Aug 8, 2025 08:30AM

Aug 8, 2025 08:30AM

Jul 22, 2025 06:44AM

Jul 21, 2025 10:33AM

Jul 20, 2025 10:52AM

Jul 18, 2025 01:43PM CAPR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Capricor Therapeutics, Inc. Investors

Jul 14, 2025 06:58AM

Jul 11, 2025 06:30AM

Jul 11, 2025 06:30AM

Jul 3, 2025 10:00AM

Jul 1, 2025 10:00AM

Jun 28, 2025 10:00AM

Jun 28, 2025 10:00AM INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR

Jun 26, 2025 02:13AM

Jun 24, 2025 01:08PM

Jun 24, 2025 12:29PM

Jun 24, 2025 10:44AM

Jun 24, 2025 09:01AM

Jun 24, 2025 09:00AM

Jun 24, 2025 06:46AM Cantor Fitzgerald Reiterates Overweight Rating on Capricor Therapeutics (CAPR)

Jun 23, 2025 06:43AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All